VX-264 Phase 1/2 enrollment and dosing complete in Parts A and B: VX-264 was generally safe and well tolerated; efficacy data are not supportive of further clinical advancement – Zimislecel… Read More
BC led research to transform early disease detection, treatment and health equity using cutting edge genomic technologies. VANCOUVER, BC — Genome BC has helped secure more than $49 million for… Read More
X-platform bioreactors are designed to help navigate challenges by combining reliability, scalability, and flexibility in one solution Scientists and researchers can seamlessly scale from 50L to 2 000L to meet… Read More
VANCOUVER, BC – The Terry Fox Research Institute launched a $25-million Digital Health Innovation Fund to fuel private- and public-sector breakthroughs focused, initially, on precision medicine for cancer and neuroscience,… Read More
Many children in Canada lack access to adequate and healthy food1 Only 39% of children and adolescents (5-17 years old) get sufficient physical activity2 Community interventions aim to increase quality… Read More
